7.68
-0.22(-2.78%)
Currency In USD
Address
890 Winter Street
Waltham, MA 02451
United States of America
Phone
781 208 2466
Website
Sector
Healthcare
Industry
Biotechnology
Employees
52
First IPO Date
October 11, 2024
| Name | Title | Pay | Year Born |
| E. Rand Sutherland | Chief Executive Officer & Director | 869,154 | 1970 |
| Allison Ambrose | Senior VP, General Counsel & Secretary | 59,792 | 1985 |
| Michael Paul Gray | Chief Financial Officer & Chief Operating Officer | 607,200 | 1971 |
| Aaron Deykin | Chief Medical Officer and Head of Research & Development | 736,700 | 1967 |
| Adam Houghton | Chief Business Officer | 0 | 1970 |
| Sumathi Sivapalasingam | VP & Head of Clinical Development | 0 | N/A |
| Meggan Buckwell | Director of Corporate Communications & Investor Relations | 0 | N/A |
| Fang Xie | VP & Head of Biometrics | 0 | N/A |
| Lisa Fiering | Senior Vice President of People & Culture | 0 | N/A |
| Mersedeh Miraliakbari | Senior Vice President of Regulatory Affairs & Quality | 0 | N/A |
| Stacy Price | Chief Technology Officer | 0 | 1969 |
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disorders. It develops verekitug, a monoclonal antibody that targets and inhibits the thymic stromal lymphopoietin receptor. The company also develops therapies to treat severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Upstream Bio, Inc. was incorporated in 2021 and is based in Waltham, Massachusetts.